Pethidine and ketorolac in biliary colic pain

Comparison of intravenous pethidine and ketorolac in reduction the biliary colic pain

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017061134367N1

Enrollment

Registered

2017-06-11

Start date

2017-06-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary colic. Calculus of gallbladder without cholecystitis

Interventions

Intervention 1: Intravenous pethidine (1 mg/kg) with maximum dose 60 mg. Intervention 2: Intravenous ketorolac (30 mg).

Treatment - Drugs

Intravenous pethidine (1 mg/kg) with maximum dose 60 mg.

Intravenous ketorolac (30 mg)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged between 30 and 60 year with biliary colic will be enrolled the study. Exclusion criteria are drug abuse and allergy for drugs.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Each 30 minutes for 1 hour. Method of measurement: Visual Analogue Scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Omid Bameri

Emam Reza hospital

Bamerio931@mums.ac.ir+98 51 3316 4058

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026